drugset / Trial / NCT05819983

Ivermectin/ Permethrin for Scabies

NCT05819983

Phase 4 Completed 60 enrolled Padjadjaran University
RandomizedParallel-groupTriple-blindTreatment

Summary

Scabies is a skin disease characterized by intense itching that worsens at night. It is very contagious, still has a high occurrence rate, and impacts patient quality of life. The use of scabicide followed by a clean and healthy lifestyle is the principle of scabies therapy. The primary treatment option for scabies is permethrin 5% cream. Ivermectin is an alternate treatment for scabies.

Timeline

Start
2023-01-25
Primary completion
2023-02-01
Completion
2023-03-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ivermectin Small molecule 200 ug/kg Oral
Comparator Permethrin Small molecule 5 % Topical

Indications